Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma

NCT00070525 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

NIH

Sponsor class

Conditions

Childhood High-grade Cerebral Astrocytoma
Childhood Oligodendroglioma
Recurrent Childhood Brain Stem Glioma
Recurrent Childhood Cerebellar Astrocytoma
Recurrent Childhood Cerebral Astrocytoma
Recurrent Childhood Medulloblastoma
Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
Recurrent Childhood Visual Pathway and Hypothalamic Glioma

Interventions

DRUG: tipifarnib

Sponsor

National Cancer Institute (NCI)